182 related articles for article (PubMed ID: 33687657)
1. EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
Zhao J; Li H; Yuan M
Genes Genomics; 2021 May; 43(5):459-470. PubMed ID: 33687657
[TBL] [Abstract][Full Text] [Related]
2. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
Huang Y; Luo F
IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
[TBL] [Abstract][Full Text] [Related]
3. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
4. Early growth response 1 promoted the invasion of glioblastoma multiforme by elevating HMGB1.
DU K; Wu X; Ji X; Liang N; Li Z
J Neurosurg Sci; 2023 Aug; 67(4):422-430. PubMed ID: 33297605
[TBL] [Abstract][Full Text] [Related]
5. EGR1 Promotes Ovarian Hyperstimulation Syndrome Through Upregulation of SOX9 Expression.
Wang H; Chen W; Huang Y; Sun Y; Liu Y; Zhu Y; Lu Z
Cell Transplant; 2023; 32():9636897231193073. PubMed ID: 37737125
[TBL] [Abstract][Full Text] [Related]
6. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
7. MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
Mei J; Zhu C; Pan L; Li M
Bioengineered; 2022 Jan; 13(1):61-70. PubMed ID: 34939526
[TBL] [Abstract][Full Text] [Related]
8. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9.
Liu CQ; Chen Y; Xie BF; Li YL; Wei YT; Wang F
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5628-5639. PubMed ID: 31298315
[TBL] [Abstract][Full Text] [Related]
10. SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth.
Wang HY; Lian P; Zheng PS
Oncotarget; 2015 Aug; 6(24):20711-22. PubMed ID: 26036262
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway.
Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H
FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
[TBL] [Abstract][Full Text] [Related]
14. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
[TBL] [Abstract][Full Text] [Related]
15. Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.
Chen C; Li HF; Hu YJ; Jiang MJ; Liu QS; Zhou J
Yonsei Med J; 2019 Jul; 60(7):611-618. PubMed ID: 31250574
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
17. PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer.
Chen R; Sheng C; Ma R; Zhang L; Yang L; Chen Y
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34523695
[TBL] [Abstract][Full Text] [Related]
18. Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis.
Li N; Piao J; Wang X; Kim KY; Bae JY; Ren X; Lin Z
Cancer Res Treat; 2019 Oct; 51(4):1653-1665. PubMed ID: 31010277
[TBL] [Abstract][Full Text] [Related]
19. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
[TBL] [Abstract][Full Text] [Related]
20. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.
Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]